SlideShare a Scribd company logo
1 of 20
Download to read offline
Aug 25, 2023
Emil L Fosbøl
New indications in
antibiotic therapy
2023 ESC Guidelines for the management of
endocarditis
www.escardio.org/guidelines
©ESC
www.escardio.org/guidelines
©ESC
2023 ESC Guidelines for the management of endocarditis
(European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193)
2023 ESC Guidelines on Endocarditis
Agenda
• Novel aspects of antibiotic treatment in 2023 guidelines
• Per oral + out-patient parental treatment (OPAT) and underlying data
• A new paradigm in endocarditis treatment
www.escardio.org/guidelines
©ESC
2023 ESC Guidelines for the management of endocarditis
(European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193)
2023 ESC Guidelines on Endocarditis
Changes/trends in the new guidelines and novel aspects
• Reinforced: The endocarditis team is at the centre of treatment
decisions
• Similar: Prophylactic, empirical and targeted antibiotic therapy
similar to 2015 ESC guidelines
• Novel: The introduction of oral antibiotic therapy or OPAT
www.escardio.org/guidelines
©ESC
2023 ESC Guidelines for the management of endocarditis
(European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193)
2023 ESC Guidelines on Endocarditis
Reinforced:
• The endocarditis team is at
the centre
• Managing expert team
• Cardiologist
• Surgeons
• Microbiologists
• Infectious diseases
experts…
www.escardio.org/guidelines
©ESC
2023 ESC Guidelines for the management of endocarditis
(European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193)
2023 ESC Guidelines on Endocarditis
2015 Class Level 2023 Class Level
Recommendations for antibiotic prophylaxis in patients with cardiovascular diseases
undergoing oro-dental procedures at increased risk for infective endocarditis
Antibiotic prophylaxis should be
considered for patients at highest
risk for IE:
1. Patients with any prosthetic
valve, including a transcatheter
valve, or those in whom any
prosthetic material was used for
cardiac valve repair.
IIa C
Antibiotic prophylaxis is
recommended in patients with
previous IE.
I B
Antibiotic prophylaxis is
recommended in patients with
surgically implanted prosthetic
valves and with any material used
for surgical cardiac valve repair.
I C
Similar
www.escardio.org/guidelines
©ESC
2023 ESC Guidelines for the management of endocarditis
(European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193)
2023 ESC Guidelines on Endocarditis
Similar
• Antibiotic regimens are similar
• No new randomized data (Most are I-B/C recommendations)
• Oral regimens are new: dual oral coverage
www.escardio.org/guidelines
©ESC
2023 ESC Guidelines for the management of endocarditis
(European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193)
2023 ESC Guidelines on Endocarditis
Novel: a new outpatient paradigm for antibiotic therapy
Recommendations Class Level
Outpatient parenteral or oral antibiotic treatment should be considered in patients
with left-sided IE caused by Streptococcus spp., E. faecalis, S. aureus, or CoNS who
were receiving appropriate i.v. antibiotic treatment for at least 10 days (or at least 7
days after cardiac surgery), are clinically stable, and who do not show signs of abscess
formation or valve abnormalities requiring surgery on TOE.
IIa A
Outpatient parenteral antibiotic treatment is not recommended in patients with IE
caused by highly difficult-to-treat microorganisms, liver cirrhosis (Child-Pugh B or C),
severe cerebral nervous system emboli, untreated large extracardiac abscesses, heart
valve complications, or other severe conditions requiring surgery, severe post-surgical
complications, and PWID-related IE.
III C
www.escardio.org/guidelines
©ESC
2023 ESC Guidelines for the management of endocarditis
(European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193)
2023 ESC Guidelines on Endocarditis
Novel:
• Randomized data
• Formalizing treatment phases
• Introducing “stability”
www.escardio.org/guidelines
©ESC
2023 ESC Guidelines for the management of endocarditis
(European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193)
2023 ESC Guidelines on Endocarditis
Novel:
• Defining stability
• Stability  oral therapy
• Shorter hospitalizations and
better outcomes
www.escardio.org/guidelines
©ESC
2023 ESC Guidelines for the management of endocarditis
(European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193)
2023 ESC Guidelines on Endocarditis
Novel per oral paradigm based on the POET trial:
www.escardio.org/guidelines
©ESC
2023 ESC Guidelines for the management of endocarditis
(European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193)
POET: Baseline characteristics
www.escardio.org/guidelines
©ESC
2023 ESC Guidelines for the management of endocarditis
(European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193)
POET: Baseline characteristics
www.escardio.org/guidelines
©ESC
2023 ESC Guidelines for the management of endocarditis
(European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193)
POET primary outcome data: death, emboli, unplanned surgery, relapse
Oral group
discharged 17
days earlier
5-years FU: Oral superior to iv, HR 0.65 (0.47-0.90)
www.escardio.org/guidelines
©ESC
2023 ESC Guidelines for the management of endocarditis
(European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193)
2023 ESC Guidelines on Endocarditis
Novel per oral treatment
• Stabilization is key
• Patients may be discharged much
earlier
• Monitoring, adherence and out-
patient care is important
www.escardio.org/guidelines
©ESC
2023 ESC Guidelines for the management of endocarditis
(European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193)
2023 ESC Guidelines on Endocarditis
Case for illustration
• 63yo man
• Medical history:
• Diabetes
• Atrial fibrillation
Strep agalactiae, CRP 154, no
emboli
www.escardio.org/guidelines
©ESC
2023 ESC Guidelines for the management of endocarditis
(European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193)
2023 ESC Guidelines on Endocarditis
Case for illustration
• After 17 days iv AB:
• CRP 23
• No fever
• TEE is performed and
vegetation is only 4mm now
and valve is doing well
www.escardio.org/guidelines
©ESC
2023 ESC Guidelines for the management of endocarditis
(European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193)
2023 ESC Guidelines on Endocarditis
Case for illustration
• After 17 days iv AB: Patient is stable
2023 ESC Guidelines
2015 ESC Guidelines
4–6 weeks iv treatment
in-hospital
Switched after 17 days to double
oral antibiotic treatment,
discharged and seen twice per
week. Total of 4–6 weeks therapy
www.escardio.org/guidelines
©ESC
2023 ESC Guidelines for the management of endocarditis
(European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193)
2023 ESC Guidelines on Endocarditis
Take home messages
• The 2023 ESC guidelines reinforce use of antibiotic prophylaxis and
empirical + targeted antibiotic therapy
• The 2023 ESC guidelines introduce a novel treatment paradigm for
endocarditis: oral/out-patient treatment after stabilization
www.escardio.org/guidelines
©ESC
Clinical Practice Guidelines Webinar
SEPTEMBER 2023 on ESC365

More Related Content

Similar to New indications in antibiotic therapy in ACS

art%3A10.1007%2Fs12471-011-0223-0
art%3A10.1007%2Fs12471-011-0223-0art%3A10.1007%2Fs12471-011-0223-0
art%3A10.1007%2Fs12471-011-0223-0
Bob Oude Velthuis
 
Guía de manejo de la Esc 2023 en síndrome coronario agudo
Guía de manejo de la Esc 2023 en síndrome coronario agudoGuía de manejo de la Esc 2023 en síndrome coronario agudo
Guía de manejo de la Esc 2023 en síndrome coronario agudo
KarlaGonzlez356645
 
ClinicalOutcomesFollowingCoronary BifurcationPCITechniques.pdf
ClinicalOutcomesFollowingCoronary BifurcationPCITechniques.pdfClinicalOutcomesFollowingCoronary BifurcationPCITechniques.pdf
ClinicalOutcomesFollowingCoronary BifurcationPCITechniques.pdf
Irving Torres Lopez
 

Similar to New indications in antibiotic therapy in ACS (20)

Non ST Elevation Myocardial Infarction
Non ST Elevation Myocardial InfarctionNon ST Elevation Myocardial Infarction
Non ST Elevation Myocardial Infarction
 
art%3A10.1007%2Fs12471-011-0223-0
art%3A10.1007%2Fs12471-011-0223-0art%3A10.1007%2Fs12471-011-0223-0
art%3A10.1007%2Fs12471-011-0223-0
 
Af and acs guideline
Af and acs guidelineAf and acs guideline
Af and acs guideline
 
2020 ESC Guidelines of AF
2020 ESC Guidelines of AF2020 ESC Guidelines of AF
2020 ESC Guidelines of AF
 
atrial fibrillation 2020 guidelines
atrial fibrillation 2020 guidelinesatrial fibrillation 2020 guidelines
atrial fibrillation 2020 guidelines
 
2020 esc guidelines for the diagnosis and management of atrial fibrillation. ...
2020 esc guidelines for the diagnosis and management of atrial fibrillation. ...2020 esc guidelines for the diagnosis and management of atrial fibrillation. ...
2020 esc guidelines for the diagnosis and management of atrial fibrillation. ...
 
2020-ACHD-for-web.pptx
2020-ACHD-for-web.pptx2020-ACHD-for-web.pptx
2020-ACHD-for-web.pptx
 
Guía síndrome coronario agudo.pdf Guía síndrome coronario agudo.pdf
Guía síndrome coronario agudo.pdf Guía síndrome coronario agudo.pdfGuía síndrome coronario agudo.pdf Guía síndrome coronario agudo.pdf
Guía síndrome coronario agudo.pdf Guía síndrome coronario agudo.pdf
 
ACS ESCGL 2023.pdf
ACS ESCGL 2023.pdfACS ESCGL 2023.pdf
ACS ESCGL 2023.pdf
 
All acs-guidelines-jan-2016
All acs-guidelines-jan-2016All acs-guidelines-jan-2016
All acs-guidelines-jan-2016
 
management of af.pptx
management of af.pptxmanagement of af.pptx
management of af.pptx
 
diferencias-FA-2019-a-2020.pdf
diferencias-FA-2019-a-2020.pdfdiferencias-FA-2019-a-2020.pdf
diferencias-FA-2019-a-2020.pdf
 
j.jacc.2023.06.006.pdf
j.jacc.2023.06.006.pdfj.jacc.2023.06.006.pdf
j.jacc.2023.06.006.pdf
 
Resucitacion
Resucitacion Resucitacion
Resucitacion
 
Guía de manejo de la Esc 2023 en síndrome coronario agudo
Guía de manejo de la Esc 2023 en síndrome coronario agudoGuía de manejo de la Esc 2023 en síndrome coronario agudo
Guía de manejo de la Esc 2023 en síndrome coronario agudo
 
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
 
NCCN ESOFAGO.pdf
NCCN ESOFAGO.pdfNCCN ESOFAGO.pdf
NCCN ESOFAGO.pdf
 
Pharmacogenomics into practice - stroke services and a systems approach
Pharmacogenomics into practice - stroke services and a systems approachPharmacogenomics into practice - stroke services and a systems approach
Pharmacogenomics into practice - stroke services and a systems approach
 
Presentation1 organ support technique.pptx
Presentation1 organ support technique.pptxPresentation1 organ support technique.pptx
Presentation1 organ support technique.pptx
 
ClinicalOutcomesFollowingCoronary BifurcationPCITechniques.pdf
ClinicalOutcomesFollowingCoronary BifurcationPCITechniques.pdfClinicalOutcomesFollowingCoronary BifurcationPCITechniques.pdf
ClinicalOutcomesFollowingCoronary BifurcationPCITechniques.pdf
 

Recently uploaded

Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
MedicoseAcademics
 

Recently uploaded (20)

Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES exam
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 ppt
 
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
 
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
 
TEST BANK for Wilkins’ Clinical Assessment in Respiratory Care, 9th Edition b...
TEST BANK for Wilkins’ Clinical Assessment in Respiratory Care, 9th Edition b...TEST BANK for Wilkins’ Clinical Assessment in Respiratory Care, 9th Edition b...
TEST BANK for Wilkins’ Clinical Assessment in Respiratory Care, 9th Edition b...
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
 
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt)  CAS 5449-12-7 Pharmaceutical intermediatesBMK Glycidic Acid (sodium salt)  CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
PREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptxPREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptx
 
Pharmacology of drugs acting on Renal System.pdf
Pharmacology of drugs acting on Renal System.pdfPharmacology of drugs acting on Renal System.pdf
Pharmacology of drugs acting on Renal System.pdf
 
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
hypo and hyper thyroidism final lecture.pptx
hypo and hyper thyroidism  final lecture.pptxhypo and hyper thyroidism  final lecture.pptx
hypo and hyper thyroidism final lecture.pptx
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 

New indications in antibiotic therapy in ACS

  • 1. Aug 25, 2023 Emil L Fosbøl New indications in antibiotic therapy 2023 ESC Guidelines for the management of endocarditis
  • 3. www.escardio.org/guidelines ©ESC 2023 ESC Guidelines for the management of endocarditis (European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193) 2023 ESC Guidelines on Endocarditis Agenda • Novel aspects of antibiotic treatment in 2023 guidelines • Per oral + out-patient parental treatment (OPAT) and underlying data • A new paradigm in endocarditis treatment
  • 4. www.escardio.org/guidelines ©ESC 2023 ESC Guidelines for the management of endocarditis (European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193) 2023 ESC Guidelines on Endocarditis Changes/trends in the new guidelines and novel aspects • Reinforced: The endocarditis team is at the centre of treatment decisions • Similar: Prophylactic, empirical and targeted antibiotic therapy similar to 2015 ESC guidelines • Novel: The introduction of oral antibiotic therapy or OPAT
  • 5. www.escardio.org/guidelines ©ESC 2023 ESC Guidelines for the management of endocarditis (European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193) 2023 ESC Guidelines on Endocarditis Reinforced: • The endocarditis team is at the centre • Managing expert team • Cardiologist • Surgeons • Microbiologists • Infectious diseases experts…
  • 6. www.escardio.org/guidelines ©ESC 2023 ESC Guidelines for the management of endocarditis (European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193) 2023 ESC Guidelines on Endocarditis 2015 Class Level 2023 Class Level Recommendations for antibiotic prophylaxis in patients with cardiovascular diseases undergoing oro-dental procedures at increased risk for infective endocarditis Antibiotic prophylaxis should be considered for patients at highest risk for IE: 1. Patients with any prosthetic valve, including a transcatheter valve, or those in whom any prosthetic material was used for cardiac valve repair. IIa C Antibiotic prophylaxis is recommended in patients with previous IE. I B Antibiotic prophylaxis is recommended in patients with surgically implanted prosthetic valves and with any material used for surgical cardiac valve repair. I C Similar
  • 7. www.escardio.org/guidelines ©ESC 2023 ESC Guidelines for the management of endocarditis (European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193) 2023 ESC Guidelines on Endocarditis Similar • Antibiotic regimens are similar • No new randomized data (Most are I-B/C recommendations) • Oral regimens are new: dual oral coverage
  • 8. www.escardio.org/guidelines ©ESC 2023 ESC Guidelines for the management of endocarditis (European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193) 2023 ESC Guidelines on Endocarditis Novel: a new outpatient paradigm for antibiotic therapy Recommendations Class Level Outpatient parenteral or oral antibiotic treatment should be considered in patients with left-sided IE caused by Streptococcus spp., E. faecalis, S. aureus, or CoNS who were receiving appropriate i.v. antibiotic treatment for at least 10 days (or at least 7 days after cardiac surgery), are clinically stable, and who do not show signs of abscess formation or valve abnormalities requiring surgery on TOE. IIa A Outpatient parenteral antibiotic treatment is not recommended in patients with IE caused by highly difficult-to-treat microorganisms, liver cirrhosis (Child-Pugh B or C), severe cerebral nervous system emboli, untreated large extracardiac abscesses, heart valve complications, or other severe conditions requiring surgery, severe post-surgical complications, and PWID-related IE. III C
  • 9. www.escardio.org/guidelines ©ESC 2023 ESC Guidelines for the management of endocarditis (European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193) 2023 ESC Guidelines on Endocarditis Novel: • Randomized data • Formalizing treatment phases • Introducing “stability”
  • 10. www.escardio.org/guidelines ©ESC 2023 ESC Guidelines for the management of endocarditis (European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193) 2023 ESC Guidelines on Endocarditis Novel: • Defining stability • Stability  oral therapy • Shorter hospitalizations and better outcomes
  • 11. www.escardio.org/guidelines ©ESC 2023 ESC Guidelines for the management of endocarditis (European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193) 2023 ESC Guidelines on Endocarditis Novel per oral paradigm based on the POET trial:
  • 12. www.escardio.org/guidelines ©ESC 2023 ESC Guidelines for the management of endocarditis (European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193) POET: Baseline characteristics
  • 13. www.escardio.org/guidelines ©ESC 2023 ESC Guidelines for the management of endocarditis (European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193) POET: Baseline characteristics
  • 14. www.escardio.org/guidelines ©ESC 2023 ESC Guidelines for the management of endocarditis (European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193) POET primary outcome data: death, emboli, unplanned surgery, relapse Oral group discharged 17 days earlier 5-years FU: Oral superior to iv, HR 0.65 (0.47-0.90)
  • 15. www.escardio.org/guidelines ©ESC 2023 ESC Guidelines for the management of endocarditis (European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193) 2023 ESC Guidelines on Endocarditis Novel per oral treatment • Stabilization is key • Patients may be discharged much earlier • Monitoring, adherence and out- patient care is important
  • 16. www.escardio.org/guidelines ©ESC 2023 ESC Guidelines for the management of endocarditis (European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193) 2023 ESC Guidelines on Endocarditis Case for illustration • 63yo man • Medical history: • Diabetes • Atrial fibrillation Strep agalactiae, CRP 154, no emboli
  • 17. www.escardio.org/guidelines ©ESC 2023 ESC Guidelines for the management of endocarditis (European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193) 2023 ESC Guidelines on Endocarditis Case for illustration • After 17 days iv AB: • CRP 23 • No fever • TEE is performed and vegetation is only 4mm now and valve is doing well
  • 18. www.escardio.org/guidelines ©ESC 2023 ESC Guidelines for the management of endocarditis (European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193) 2023 ESC Guidelines on Endocarditis Case for illustration • After 17 days iv AB: Patient is stable 2023 ESC Guidelines 2015 ESC Guidelines 4–6 weeks iv treatment in-hospital Switched after 17 days to double oral antibiotic treatment, discharged and seen twice per week. Total of 4–6 weeks therapy
  • 19. www.escardio.org/guidelines ©ESC 2023 ESC Guidelines for the management of endocarditis (European Heart Journal; 2023 – doi: 10.1093/eurheartj/ehad193) 2023 ESC Guidelines on Endocarditis Take home messages • The 2023 ESC guidelines reinforce use of antibiotic prophylaxis and empirical + targeted antibiotic therapy • The 2023 ESC guidelines introduce a novel treatment paradigm for endocarditis: oral/out-patient treatment after stabilization